LifeNet Health’s ViviGen MIS optimizes leading cellular allograft for minimally invasive procedures
LifeNet Health’s ViviGen MIS optimizes leading cellular allograft for minimally invasive procedures
Boston, Mass. (Sept. 28, 2021) — LifeNet Health, the world leader in allograft biologics, has optimized its industry-leading cellular bone matrix for minimally invasive surgery with the launch of ViviGen® MIS Delivery System, a major improvement in precision, efficiency and reliability over traditional bone-graft delivery.